Mathias Hukkelhoven's Net Worth

$0

Estimate Recalculated Jun 27, 2024 03:37PM EST

Who is Mathias Hukkelhoven?

Mathias Hukkelhoven does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Centessa Pharmaceuticals plc.

SEC CIK

Mathias Hukkelhoven's CIK is 0001936319

Past Insider Trading and Trends

2022 was Mathias Hukkelhoven's most active year for acquiring shares with 1 total transactions. Mathias Hukkelhoven's most active month to acquire stocks was the month of May. 2022 saw Mathias Hukkelhoven paying a total of $0.00 for 96,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Centessa Pharmaceuticals plc (CNTA) Snapshot price: $7.62

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found